- Helping independents compete in specialty pharmacy, Cardinal Health launches new suite of services at RBC 2013
- Jim Cramer gets bullish on Rite Aid on 'Mad Money'
- Walgreens expanding scope of retail pharmacy experience and services heading into fiscal 2014
- Green Equity Investors exchanges nearly 1.9 million shares of Rite Aid preferred stock for common stock
- Walgreens and Express Scripts offer Smart90 Walgreens — a 90-day fill at retail — to improve adherence
ST. LOUIS — In an amendment dated Nov. 7 and filed to the Securities Exchange Commission on Tuesday, Express Scripts reduced its termination fee by 32% to $650 million. The termination fee is paid to one company when the other terminates the merger agreement.
The change was made to settle lawsuits against Medco accusing the company of selling itself too cheaply to Express Scripts, according to a research note by Bank of America Merrill Lynch analysts published on Tuesday, as reported by the New York Times. The lower fee may create more interest among rivals hoping to compete for Medco, the analysis concluded.